Alpine Immune Sciences Inc ALPN:NASDAQ

Last Price$7.95NASDAQ Previous Close - Last Trade as of 4:00PM ET 5/18/22

Today's Change-0.05(0.62%)
Bid (Size)$6.00 (8)
Ask (Size)$9.00 (5)
Day Low / High$7.66 - 8.09
Volume79.3 K

Horizon Therapeutics Working With Alpine Immune Sciences to Develop Therapies for Autoimmune, Inflammatory Diseases

9:02AM ET 12/16/2021 MT Newswires
Horizon Therapeutics (HZNP) and Alpine Immune Sciences (ALPN) on Thursday entered into an exclusive agreement to develop novel protein-based therapies for autoimmune and inflammatory diseases using Alpine's discovery platform.

The agreement includes the licensing of a lead preclinical candidate and a research collaboration for additional novel candidates. Alpine will advance candidate molecules to pre-defined preclinical milestones, while Horizon will be responsible for the development and commercialization activities and costs.

Under the terms of the partnership, Horizon will pay $25 million upfront to Alpine and make a $15 million equity investment. Alpine will also be eligible to receive up to $1.52 billion in milestone payments and sales royalties.

Shares of Alpine rose 7.7% during the recent premarket trading activity, while Horizon was unchanged.

Price: 107.85, Change: +1.12, Percent Change: +1.05